AAAAAA
Results: 1-25/79
Authors:
CAVROIS M
LECLERCQ I
GOUT O
GESSAIN A
WAINHOBSON S
WATTEL E
Citation: M. Cavrois et al., PERSISTENT OLIGOCLONAL EXPANSION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 INFECTED CIRCULATING CELLS IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS HTLV-1 ASSOCIATED MYELOPATHY, Oncogene, 17(1), 1998, pp. 77-82
Authors:
ADAMS EW
SCHLAGER W
WATTEL E
Citation: Ew. Adams et al., SUBMARINE SLOPES WITH AN EXPONENTIAL CURVATURE, Sedimentary geology, 117(3-4), 1998, pp. 135-141
Authors:
WATTEL E
SOLARY E
HECQUET B
CAILLOT D
IFRAH N
BRION A
MAHE B
MILPIED N
JANVIER M
GUERCI A
ROCHANT H
CORDONNIER C
DREYFUS F
BUZYN A
HOANGNGOC L
STOPPA AM
GRATECOS N
SADOUN A
STAMATOULAS A
TILLY H
BRICE P
MALOISEL F
LIOURE B
DESABLENS B
PIGNON B
ABGRALL JP
LEPORRIER M
DUPRIEZ B
GUYOTAT D
LEPELLEY P
FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
Authors:
WATTEL E
SOLARY E
HECQUET B
CAILLOT D
IFRAH N
BRION A
MILPIED N
JANVIER M
GUERCI A
ROCHANT H
CORDONNIER C
DREYFUS F
VEIL A
HOANGNGOC L
STOPPA AM
GRATECOS N
SADOUN A
TILLY H
BRICE B
GUYOTAT D
LEPELLEY P
FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(1), 1998, pp. 282-282
Authors:
WATTEL E
LELEU X
SOLARY E
CAILLOT D
DREYFUS F
BRION A
MAHE B
JOUET JP
HOANGNGOC L
MALOISEL F
GUERCI A
ROCHANT H
GRATECOS N
SADOUN A
STAMATOULLAS A
CASASSUS P
JANVIER M
STOPPA AM
DESABLENS B
FEGUEUX N
GUYOTAT D
BRICE P
LEPELLEY P
FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 320-321
Authors:
LECLERCQ I
CAVROIS M
MORTREUX F
HERMINE O
GESSAIN A
MORSCHHAUSER F
WATTEL E
Citation: I. Leclercq et al., OLIGOCLONAL PROLIFERATION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 BEARING T-CELLS IN ADULT T-CELL LEUKAEMIA LYMPHOMA WITHOUT DELETION OF THE 3'-PROVIRUS INTEGRATION SITES/, British Journal of Haematology, 101(3), 1998, pp. 500-506
Authors:
QUESNEL B
GUILLERM G
VEREECQUE R
WATTEL E
PREUDHOMME C
BAUTERS F
VANRUMBEKE M
PIERREFENAUX P
Citation: B. Quesnel et al., METHYLATION OF THE P15(INK4A) GENE IN MYELODYSPLASTIC SYNDROMES IS FREQUENT AND ACQUIRED DURING DISEASE PROGRESSION, Blood, 91(8), 1998, pp. 2985-2990
Authors:
STERKERS Y
PREUDHOMME C
LAI JL
DEMORY JL
CAULIER MT
WATTEL E
BORDESSOULE D
BAUTERS F
FENAUX P
Citation: Y. Sterkers et al., ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES FOLLOWING ESSENTIAL THROMBOCYTHEMIA TREATED WITH HYDROXYUREA - HIGH PROPORTION OF CASES WITH 17P DELETION, Blood, 91(2), 1998, pp. 616-622
Authors:
CAMBIER N
BARUCHEL A
SCHLAGETER MH
MENOT ML
WATTEL E
FENAUX P
CHOMIENNE C
Citation: N. Cambier et al., CHRONIC MYELOMONOCYTIC LEUKEMIA - FROM BIOLOGY TO THERAPY, HEM CELL TH, 39(2), 1997, pp. 41-48
Authors:
HEBBAR M
KOZLOWSKI D
WATTEL E
MASTRINI S
DIEVART M
DUCLOS B
BONAZ B
DALMAGNE H
BELAICHE J
COLOMBEL JF
FENAUX P
Citation: M. Hebbar et al., ASSOCIATION BETWEEN MYELODYSPLASTIC SYNDROMES AND INFLAMMATORY BOWEL DISEASES - REPORT OF 7 NEW CASES AND REVIEW OF THE LITERATURE, Leukemia, 11(12), 1997, pp. 2188-2191
Authors:
WATTEL E
LEPELLEY P
Citation: E. Wattel et P. Lepelley, MULTIDRUG-RESISTANCE IN MYELODYSPLASTIC S YNDROMES - A POTENTIAL ROLEFOR REVERSION-INDUCING AGENTS, Pathologie et biologie, 45(8), 1997, pp. 637-642
Authors:
WATTEL E
SOLARY E
CAILLOT D
DREYFUS F
BRION A
MAHE B
HOANGNGOC L
MALOISEL F
GUERCI A
ROCHANT H
GRATECOS N
SADOUN A
STAMATOULLAS A
CASASSUS P
JANVIER M
STOPPA AM
DESABLENS B
FEGEUX N
IFRAH N
ABGRALL JP
GUYOTAT D
DUPRIEZ B
PENY AM
BRICE P
PIGNON B
LEPORRIER M
LEPELLEY P
FENAUX P
Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 34-34
Authors:
WATTEL E
SOLARY E
CAILLOT D
DREYFUS F
BRION A
MAHE B
JOUET JP
HOANGNGOC L
MALOISEL F
GUERCI A
ROCHANT H
GRATECOS N
SADOUN A
STAMATOULLAS A
CASASSUS P
JANVIER M
STOPPA AM
DESABLENS B
FEGEUX N
GUYOTAT D
BRICE P
LEPELLEY P
FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 320-320
Authors:
CAVROIS M
LECLERCQ I
WATTEL E
Citation: M. Cavrois et al., THE OLIGOCLONAL PROLIFERATION PATTERN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 (HTLV-1) BEARING T-CELLS IN ADULT-CELL LEUKEMIA LYMPHOMA (ATLL)IS NOT ASSOCIATED WITH DELETION OF THE 3'-PROVIRUS INTEGRATION SITES/, Experimental hematology, 25(8), 1997, pp. 389-389
Authors:
CAVROIS M
LECLERCQ I
GOUT O
GESSAIN A
WAINHOBSON S
WATTEL E
Citation: M. Cavrois et al., PERSISTENT CLONAL EXPANSION OF INFECTED CIRCULATING CELLS IN PATIENTSWITH TROPICAL SPASTIC PARAPARESIS HTLV-1 ASSOCIATED MYELOPATHY (TSP HAM)/, Experimental hematology, 25(8), 1997, pp. 390-390
Authors:
DEBOTTON S
WATTEL E
BAUTERS F
FENAUX P
Citation: S. Debotton et al., LONG-TERM SURVIVAL AFTER INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - LILLES EXPERIENCE, Experimental hematology, 25(8), 1997, pp. 487-487
Authors:
WATTEL E
DEBOTTON S
HEBBAR M
MERLAT A
BAUTERS F
FENAUX P
Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - OUTCOME OF PATIENTS WHO ACHIEVED PARTIAL REMISSION (PR), Experimental hematology, 25(8), 1997, pp. 488-488
Authors:
KOZLOWSKI D
HEBBAR M
WATTEL E
BELAICHE J
BONAZ B
COLOMBEL JF
FENAUX P
Citation: D. Kozlowski et al., CONCURRENCE OF INFLAMMATORY BOWEL-DISEASE AND MYELODYSPLASTIC SYNDROMES, Gut, 41, 1997, pp. 177-178
Authors:
WATTEL E
DEBOTTON S
LAI JL
PREUDHOMME C
LEPELLEY P
BAUTERS F
FENAUX P
Citation: E. Wattel et al., LONG-TERM FOLLOW-UP OF DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED WITHINTENSIVE CHEMOTHERAPY - INCIDENCE OF LONG-TERM SURVIVORS AND OUTCOMEOF PARTIAL RESPONDERS, British Journal of Haematology, 98(4), 1997, pp. 983-991
Authors:
MORTREUX F
LECLERCQ I
GESSAINE A
CAVROIS M
WATTEL E
Citation: F. Mortreux et al., SOMATIC MUTATIONS OF THE HTLV-1 SEQUENCE IN A PATIENT WITHOUT MALIGNANCY, Blood, 90(10), 1997, pp. 3604-3604
Authors:
MOREL P
MONCONDUIT M
JACOMY D
LENAIN P
GROSBOIS JM
FACON T
BATELI C
BAUTERS F
NAJMAN A
DEGRAMONT A
WATTEL E
Citation: P. Morel et al., A NEW SCORING SYSTEM IN WALDENSTROMS MACROGLOBULINEMIA (WM) - DESCRIPTION ON 232 PATIENTS (PTS) WITH VALIDATION ON 167 OTHER PTS, Blood, 90(10), 1997, pp. 1069-1069
Authors:
WATTEL E
CAVROIS M
GESSAIN A
WAINHOBSON S
Citation: E. Wattel et al., CLONAL EXPANSION OF INFECTED-CELLS - A WAY OF LIFE FOR HTLV-I, Journal of acquired immune deficiency syndromes and human retrovirology, 13, 1996, pp. 92-99
Authors:
CAMBIER N
WATTEL E
MENOT ML
GUERCI A
CHOMIENNE C
FENAUX P
Citation: N. Cambier et al., ALL-TRANS-RETINOIC ACID IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA - RESULTS OF A PILOT-STUDY, Leukemia, 10(7), 1996, pp. 1164-1167
Authors:
WATTEL E
VANRUMBEKE M
ABINA MA
CAMBIER N
PREUDHOMME C
HADDADA H
FENAUX P
Citation: E. Wattel et al., DIFFERENTIAL EFFICACY OF ADENOVIRAL MEDIATED GENE-TRANSFER INTO CELLSFROM HEMATOLOGICAL CELL-LINES AND FRESH HEMATOLOGICAL MALIGNANCIES, Leukemia, 10(1), 1996, pp. 171-174
Authors:
HEBBAR M
KAPLAN C
CAULIER MT
WATTEL E
MOREL P
WETTERWALD M
BAUTERS F
FENAUX P
Citation: M. Hebbar et al., LOW INCIDENCE OF SPECIFIC ANTIPLATETLET ANTIBODIES DETECTED BY THE MAIPA ASSAY IN THE SERUM OF THROMBOCYTOPENIC MDS PATIENTS AND LACK OF CORRELATION BETWEEN PLATELET AUTOANTIBODIES, PLATELET LIFE-SPAN AND RESPONSE TO DANAZOL THERAPY, British Journal of Haematology, 94(1), 1996, pp. 112-115